# CraniSeal Post Approval Study

> **NCT06406790** · PHASE4 · RECRUITING · sponsor: **Pramand LLC** · enrollment: 224 (estimated)

## Conditions studied

- Leak, Cerebrospinal Fluid

## Interventions

- **DEVICE:** CraniSeal
- **DEVICE:** DuraSeal

## Key facts

- **NCT ID:** NCT06406790
- **Lead sponsor:** Pramand LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-29
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06406790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06406790, "CraniSeal Post Approval Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06406790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*